Heartflow, Inc. Proceeds from Stock Options Exercised
Heartflow, Inc. (HTFL) reported Proceeds from Stock Options Exercised of $6.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-13
- Heartflow, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $3.23M, a 278.64% increase year-over-year.
- Heartflow, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $3.34M, a 478.20% increase year-over-year.
- Heartflow, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $857.00K, a 37.40% decline year-over-year.
- Heartflow, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $1.01M, a 32.64% decline year-over-year.
- Heartflow, Inc. proceeds from stock options exercised for fiscal 2025 was $3.30M, a 27.74% decline from fiscal 2024.
- Heartflow, Inc. proceeds from stock options exercised for fiscal 2024 was $4.56M, a 674.87% increase from fiscal 2023.
- Heartflow, Inc. proceeds from stock options exercised for fiscal 2023 was $589.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $6.57M 10-Q · filed 2026-08-13 | $7.42M derived: sum of 3 quarters · filed 2026-08-13 | $8.44M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $3.34M 10-Q · filed 2026-05-14 | $4.20M derived: sum of 2 quarters · filed 2026-05-14 | $5.21M derived: sum of 3 quarters · filed 2026-05-14 | $6.06M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.87M derived: sum of 2 quarters · filed 2026-03-18 | $2.72M derived: sum of 3 quarters · filed 2026-08-13 | $3.30M 10-K · filed 2026-03-18 |
| 2025-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.86M derived: sum of 2 quarters · filed 2026-08-13 | $2.44M 10-Q · filed 2025-11-12 | $3.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $852.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.43M 10-Q · filed 2026-08-13 | $2.80M derived: sum of 3 quarters · filed 2026-08-13 | $4.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $578.00K 10-Q · filed 2026-05-14 | $1.95M derived: sum of 2 quarters · filed 2026-05-14 | $3.45M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $2.87M derived: sum of 2 quarters · filed 2026-03-18 | $4.56M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.19M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $1.69M 10-Q · filed 2025-09-19 | |||
| 2023-12-31 | $589.00K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |